Commercializing Biomarkers in Therapeutic & Diagnostic Applications Market Growth Prospects, Competitive Analysis, Upcoming Trend and Forecast 2032
In 2022, the global market size for commercializing biomarkers in therapeutic and diagnostic applications amounted to USD 15.78 Billion, with a projected growth to reach USD 51.32 Billion by 2032. This represents a compound annual growth rate (CAGR) of 14% during the forecast period. The increase in market revenue is attributed to the prevalence of chronic diseases, a growing demand for personalized medication, and advancements in Proteomics and Genomics technologies.